Skip to content
Virostem Biotechnology logo — Gene Editing Technologies and Applications

Virostem Biotechnology

Gene Editing Technologies and Applications

Founded 2020 Turkey Turkey 2 employees Biotechnology, Life Sciences

General Information

Company Name Virostem Biotechnology
Founded Year 2020
Location Turkey Turkey
Employees 2
Industries Biotechnology, Life Sciences
Social

BounceWatch is an independent company data service, not affiliated with Virostem Biotechnology. To contact Virostem Biotechnology, visit virostem.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Virostem Biotechnology compare?

A PDF of Virostem Biotechnology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Virostem Biotechnology soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Virostem Biotechnology

Virostem Biotechnology is a biotechnology startup based in Turkey, founded in 2020. The company specializes in gene editing technologies and applications and has developed a range of CRISPR-based gene editing products. With a team of scientists boasting 15+ years of experience in both academic and industry settings, Virostem offers customized solutions and services for academic, clinical, and industrial researchers in the field of gene editing and gene therapy. The company prides itself on its optimized production pipeline, which allows it to offer gene editing products at competitive prices while maintaining the highest international quality standards.

Currently, there is no publicly available information regarding Virostem's last investment or the involved investors.

Business keywords: Gene Editing, CRISPR, Gene Therapy, Research and Development, Academic Research, Clinical Research, Industrial Research, Scientists, Production Pipeline, Quality Standards, Customized Solutions, Optimized Technologies, Innovation, Disruption

No funding data available for Virostem Biotechnology yet.

Virostem Biotechnology Alternatives & Competitors

View All Alternatives
Virostem Biotechnology vs
Excellos
Excellos United States

A unique full-service CDMO, setting new standards in Cell & Gene Therapy

Corporate Round
38 employees
Biotechnology, Health Care
Virostem Biotechnology vs

辉大,给患者回答 | Answering the Patients!

Series C
27 employees
Biopharma, Biotechnology
Virostem Biotechnology vs
Synthego
Synthego United States

Your Partner in CRISPR & Molecular Diagnostics

172 employees
AI, Automation

FAQ About Virostem Biotechnology

Gene Editing Technologies and Applications
Virostem Biotechnology was founded in 2020.
Virostem Biotechnology is headquartered in Turkey.
Virostem Biotechnology operates in Biotechnology and Life Sciences. Its work centres on Gene Editing, CRISPR, Gene Therapy and Research and Development.
Virostem Biotechnology has approximately 2 employees.
Top alternatives and competitors to Virostem Biotechnology include Excellos, HuidaGene Therapeutics, Synthego, Spotlight Therapeutics, The Electrospinning Company Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Virostem Biotechnology and Excellos are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Virostem Biotechnology, https://bouncewatch.com/company/virostem-biotechnology, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout